| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.036 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |